<p>-Orally administered MORF-057 achieved primary endpoint and demonstrates clinically meaningful improvements across secondary and exploratory measures- -Clinical improvement consistently seen
<p>US 500 index rebounds from its September low Bulls attack the 50-day SMA Momentum indicators point to short-term gains The US 500 stock index (cash) is currently testing the 50-day simple mov
Leave a Comment